188 related articles for article (PubMed ID: 24987862)
1. Management of dyslipidemia in patients with human immunodeficiency virus.
Shalit P
Rev Cardiovasc Med; 2014; 15 Suppl 1():S38-46. PubMed ID: 24987862
[TBL] [Abstract][Full Text] [Related]
2. Impact of antiretroviral medications on fasting lipid parameters.
Guaraldi G; Santoro A; Stentarelli C; Luzi K
Rev Cardiovasc Med; 2014; 15 Suppl 1():S30-7. PubMed ID: 24987861
[TBL] [Abstract][Full Text] [Related]
3. Lipid metabolism in treated HIV Infection.
Dubé MP; Cadden JJ
Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):429-42. PubMed ID: 21663837
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia and lipid management in HIV-infected patients.
Lo J
Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):144-7. PubMed ID: 21297466
[TBL] [Abstract][Full Text] [Related]
5. Evidence on the Protective Role of High-Density Lipoprotein (HDL) in HIV-Infected Individuals.
Calmy A; Montecucco F; James RW
Curr Vasc Pharmacol; 2015; 13(2):167-72. PubMed ID: 24188489
[TBL] [Abstract][Full Text] [Related]
6. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
[TBL] [Abstract][Full Text] [Related]
7. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.
Gresele P; Falcinelli E; Momi S; Francisci D; Baldelli F
Rev Cardiovasc Med; 2014; 15 Suppl 1():S9-20. PubMed ID: 24987863
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia and its Treatment in HIV Infection.
Grunfeld C
Top HIV Med; 2010; 18(3):112-8. PubMed ID: 20921577
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular implications of HIV-induced dyslipidemia.
Giannarelli C; Klein RS; Badimon JJ
Atherosclerosis; 2011 Dec; 219(2):384-9. PubMed ID: 21722900
[TBL] [Abstract][Full Text] [Related]
10. HIV-related cardiovascular disease: any role for high-density lipoproteins?
Hudson P; Woudberg NJ; Kamau F; Strijdom H; Frias MA; Lecour S
Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1221-H1226. PubMed ID: 33006917
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk and dyslipidemia among persons living with HIV: a review.
Maggi P; Di Biagio A; Rusconi S; Cicalini S; D'Abbraccio M; d'Ettorre G; Martinelli C; Nunnari G; Sighinolfi L; Spagnuolo V; Squillace N
BMC Infect Dis; 2017 Aug; 17(1):551. PubMed ID: 28793863
[TBL] [Abstract][Full Text] [Related]
12. Lipid management in human immunodeficiency virus.
Myerson M
Cardiol Clin; 2015 May; 33(2):277-98. PubMed ID: 25939300
[TBL] [Abstract][Full Text] [Related]
13. [Lipid alterations and cardiovascular risk associated with antiretroviral therapy].
Masiá-Canuto M; Bernal-Morell E; Gutiérrez-Rodero F
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):637-48. PubMed ID: 17194390
[TBL] [Abstract][Full Text] [Related]
14. Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults.
Li J; Lai H; Chen S; Lai S
Int J STD AIDS; 2018 Jul; 29(8):781-789. PubMed ID: 29471762
[TBL] [Abstract][Full Text] [Related]
15. Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Significantly Worsens the Lipid Profile in a Real-World Setting.
Kauppinen KJ; Kivelä P; Sutinen J
AIDS Patient Care STDS; 2019 Dec; 33(12):500-506. PubMed ID: 31742421
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy with heart.
Randell P; Moyle G
Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
[TBL] [Abstract][Full Text] [Related]
17. [Lipid disorders in patients with HIV-induced diseases].
Chanu B; Valensi P
Presse Med; 2005 Sep; 34(15):1087-94. PubMed ID: 16334888
[TBL] [Abstract][Full Text] [Related]
18. The role of statins in the setting of HIV infection.
Eckard AR; McComsey GA
Curr HIV/AIDS Rep; 2015 Sep; 12(3):305-12. PubMed ID: 26126687
[TBL] [Abstract][Full Text] [Related]
19. Dyslipidemia related to antiretroviral therapy.
Estrada V; Portilla J
AIDS Rev; 2011; 13(1):49-56. PubMed ID: 21412389
[TBL] [Abstract][Full Text] [Related]
20. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.
Kotler DP
J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S79-85. PubMed ID: 18725816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
